Annual Working Capital
-$231.55 M
-$265.08 M-790.45%
December 31, 2022
Summary
- As of February 22, 2025, SRNE annual working capital is -$231.55 million, with the most recent change of -$265.08 million (-790.45%) on December 31, 2022.
- During the last 3 years, SRNE annual working capital has fallen by -$183.93 million (-386.26%).
- SRNE annual working capital is now -296.32% below its all-time high of $117.94 million, reached on December 31, 2018.
Performance
SRNE Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
-$131.84 M
-$66.97 M-103.23%
June 30, 2023
Summary
- As of February 22, 2025, SRNE quarterly working capital is -$131.84 million, with the most recent change of -$66.97 million (-103.23%) on June 30, 2023.
- Over the past year, SRNE quarterly working capital has dropped by -$66.97 million (-103.23%).
- SRNE quarterly working capital is now -177.71% below its all-time high of $169.66 million, reached on March 31, 2021.
Performance
SRNE Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
SRNE Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -790.5% | -103.2% |
| 3 y3 years | -386.3% | -103.2% |
| 5 y5 years | -370.1% | -103.2% |
SRNE Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -790.5% | at low | -203.9% | +43.1% |
| 5 y | 5-year | -790.5% | at low | -177.7% | +43.1% |
| alltime | all time | -296.3% | at low | -177.7% | +43.1% |
Sorrento Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | -$131.84 M(+103.2%) |
| Mar 2023 | - | -$64.87 M(-72.0%) |
| Dec 2022 | -$231.55 M(-790.4%) | -$231.55 M(+825.3%) |
| Sep 2022 | - | -$25.02 M(-149.3%) |
| Jun 2022 | - | $50.73 M(-60.0%) |
| Mar 2022 | - | $126.89 M(+278.4%) |
| Dec 2021 | $33.54 M(-427.3%) | $33.54 M(+31.3%) |
| Sep 2021 | - | $25.54 M(-201.4%) |
| Jun 2021 | - | -$25.19 M(-114.8%) |
| Mar 2021 | - | $169.66 M(-1755.8%) |
| Dec 2020 | -$10.25 M(-78.5%) | -$10.25 M(-173.9%) |
| Sep 2020 | - | $13.86 M(-138.1%) |
| Jun 2020 | - | -$36.34 M(-10.3%) |
| Mar 2020 | - | -$40.52 M(-14.9%) |
| Dec 2019 | -$47.62 M(-140.4%) | -$47.62 M(+5.5%) |
| Sep 2019 | - | -$45.15 M(+144.3%) |
| Jun 2019 | - | -$18.48 M(-141.5%) |
| Mar 2019 | - | $44.50 M(-62.3%) |
| Dec 2018 | $117.94 M(-339.5%) | $117.94 M(+87.7%) |
| Sep 2018 | - | $62.84 M(+309.4%) |
| Jun 2018 | - | $15.35 M(-202.6%) |
| Mar 2018 | - | -$14.96 M(-69.6%) |
| Dec 2017 | -$49.26 M(-463.0%) | -$49.26 M(+27.5%) |
| Sep 2017 | - | -$38.64 M(+106.8%) |
| Jun 2017 | - | -$18.69 M(-37.2%) |
| Mar 2017 | - | -$29.74 M(-319.2%) |
| Dec 2016 | $13.57 M(-87.7%) | $13.57 M(-62.1%) |
| Sep 2016 | - | $35.79 M(-58.0%) |
| Jun 2016 | - | $85.24 M(+96.8%) |
| Mar 2016 | - | $43.30 M(-60.7%) |
| Dec 2015 | $110.14 M(+71.1%) | $110.14 M(+11.6%) |
| Sep 2015 | - | $98.74 M(+127.3%) |
| Jun 2015 | - | $43.45 M(-17.7%) |
| Mar 2015 | - | $52.76 M(-18.0%) |
| Dec 2014 | $64.36 M(+137.0%) | $64.36 M(+73.3%) |
| Sep 2014 | - | $37.14 M(-16.6%) |
| Jun 2014 | - | $44.53 M(+71.4%) |
| Mar 2014 | - | $25.98 M(-4.3%) |
| Dec 2013 | $27.15 M | $27.15 M(+496.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2013 | - | $4.56 M(+2.6%) |
| Jun 2013 | - | $4.44 M(-51.7%) |
| Mar 2013 | - | $9.20 M(+97.0%) |
| Dec 2012 | $4.67 M(+45.9%) | $4.67 M(-22.9%) |
| Sep 2012 | - | $6.05 M(-17.2%) |
| Jun 2012 | - | $7.31 M(+229.5%) |
| Mar 2012 | - | $2.22 M(-30.6%) |
| Dec 2011 | $3.20 M(-35.4%) | $3.20 M(+70.8%) |
| Sep 2011 | - | $1.87 M(-27.5%) |
| Jun 2011 | - | $2.58 M(-28.6%) |
| Mar 2011 | - | $3.62 M(-26.9%) |
| Dec 2010 | $4.95 M(+59.4%) | $4.95 M(+205.4%) |
| Sep 2010 | - | $1.62 M(-19.3%) |
| Jun 2010 | - | $2.01 M(-20.3%) |
| Mar 2010 | - | $2.52 M(-18.8%) |
| Dec 2009 | $3.10 M(-2744.5%) | $3.10 M(-17.9%) |
| Sep 2009 | - | $3.78 M(+1388.0%) |
| Jun 2009 | - | $254.20 K(-23.8%) |
| Mar 2009 | - | $333.70 K(-384.2%) |
| Dec 2008 | -$117.40 K(-731.2%) | -$117.40 K(-126.8%) |
| Sep 2008 | - | $437.30 K(>+9900.0%) |
| Jun 2008 | - | $0.00(-100.0%) |
| Mar 2008 | - | $5400.00(-71.0%) |
| Dec 2007 | $18.60 K(-103.9%) | $18.60 K(-28.5%) |
| Sep 2007 | - | $26.00 K(-29.2%) |
| Jun 2007 | - | $36.70 K(-25.6%) |
| Mar 2007 | - | $49.30 K(-110.4%) |
| Dec 2006 | -$471.80 K(+1351.7%) | -$471.80 K(+1351.7%) |
| Sep 2006 | - | -$32.50 K(0.0%) |
| Jun 2006 | - | -$32.50 K(0.0%) |
| Mar 2006 | - | -$32.50 K(0.0%) |
| Dec 2005 | -$32.50 K(-90.5%) | -$32.50 K(-90.5%) |
| Sep 2005 | - | -$341.10 K(+0.1%) |
| Jun 2005 | - | -$340.90 K(+0.1%) |
| Mar 2005 | - | -$340.70 K(+0.1%) |
| Dec 2004 | -$340.50 K(+0.2%) | -$340.50 K(+0.1%) |
| Sep 2004 | - | -$340.30 K(+0.0%) |
| Jun 2004 | - | -$340.20 K(+0.1%) |
| Mar 2004 | - | -$340.00 K |
| Dec 2003 | -$339.80 K | - |
FAQ
- What is Sorrento Therapeutics annual working capital?
- What is the all time high annual working capital for Sorrento Therapeutics?
- What is Sorrento Therapeutics annual working capital year-on-year change?
- What is Sorrento Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Sorrento Therapeutics?
- What is Sorrento Therapeutics quarterly working capital year-on-year change?
What is Sorrento Therapeutics annual working capital?
The current annual working capital of SRNE is -$231.55 M
What is the all time high annual working capital for Sorrento Therapeutics?
Sorrento Therapeutics all-time high annual working capital is $117.94 M
What is Sorrento Therapeutics annual working capital year-on-year change?
Over the past year, SRNE annual working capital has changed by -$265.08 M (-790.45%)
What is Sorrento Therapeutics quarterly working capital?
The current quarterly working capital of SRNE is -$131.84 M
What is the all time high quarterly working capital for Sorrento Therapeutics?
Sorrento Therapeutics all-time high quarterly working capital is $169.66 M
What is Sorrento Therapeutics quarterly working capital year-on-year change?
Over the past year, SRNE quarterly working capital has changed by -$66.97 M (-103.23%)